Surgery Partners (SGRY) Competitors $22.15 +0.13 (+0.59%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$22.15 0.00 (0.00%) As of 07/3/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGRY vs. HIMS, GH, OPCH, RDNT, BTSG, SHC, CON, PRVA, WGS, and VCYTShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Surgery Partners vs. Its Competitors Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Hims & Hers Health (NYSE:HIMS) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation. Do analysts rate HIMS or SGRY? Hims & Hers Health currently has a consensus price target of $39.58, indicating a potential downside of 17.39%. Surgery Partners has a consensus price target of $33.56, indicating a potential upside of 51.49%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts clearly believe Surgery Partners is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 3 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92Surgery Partners 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70 Does the media prefer HIMS or SGRY? In the previous week, Hims & Hers Health had 67 more articles in the media than Surgery Partners. MarketBeat recorded 71 mentions for Hims & Hers Health and 4 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.66 beat Hims & Hers Health's score of 0.21 indicating that Surgery Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 12 Very Positive mention(s) 3 Positive mention(s) 50 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Surgery Partners 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is HIMS or SGRY more profitable? Hims & Hers Health has a net margin of 9.24% compared to Surgery Partners' net margin of -6.10%. Hims & Hers Health's return on equity of 22.75% beat Surgery Partners' return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health9.24% 22.75% 15.51% Surgery Partners -6.10%2.41%0.99% Which has more risk and volatility, HIMS or SGRY? Hims & Hers Health has a beta of 2.02, suggesting that its share price is 102% more volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Do insiders & institutionals believe in HIMS or SGRY? 63.5% of Hims & Hers Health shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 2.3% of Surgery Partners shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation and earnings, HIMS or SGRY? Hims & Hers Health has higher earnings, but lower revenue than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B7.26$126.04M$0.6969.44Surgery Partners$3.11B0.91-$168.10M-$1.53-14.48 SummaryHims & Hers Health beats Surgery Partners on 11 of the 16 factors compared between the two stocks. Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.84B$7.31B$5.53B$9.05BDividend YieldN/A2.78%5.24%4.03%P/E Ratio-14.4827.9427.5020.21Price / Sales0.9132.39421.02118.64Price / Cash11.8222.0136.8958.07Price / Book0.886.698.045.67Net Income-$168.10M$233.06M$3.18B$249.13M7 Day Performance0.91%1.74%2.82%3.30%1 Month Performance-3.95%3.97%3.70%5.20%1 Year Performance-6.14%35.84%35.41%21.38% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners2.6276 of 5 stars$22.15+0.6%$33.56+51.5%-6.1%$2.84B$3.11B-14.4815,000HIMSHims & Hers Health2.2042 of 5 stars$42.09-34.5%$38.00-9.7%+134.1%$9.42B$1.48B61.001,637Trending NewsInsider TradeHigh Trading VolumeGHGuardant Health3.7443 of 5 stars$48.55-1.2%$53.76+10.7%+76.9%$6.01B$774.00M-14.322,021Insider TradeOPCHOption Care Health4.3729 of 5 stars$31.05-1.5%$35.50+14.3%+11.5%$5.08B$5.19B25.048,088Positive NewsRDNTRadNet3.6927 of 5 stars$54.87-0.7%$69.60+26.8%-5.2%$4.12B$1.83B-127.6011,021BTSGBrightSpring Health Services1.6276 of 5 stars$22.77+2.2%$24.90+9.4%+95.5%$4.00B$11.27B81.3235,000SHCSotera Health3.0012 of 5 stars$11.09-2.6%$15.80+42.5%+0.8%$3.15B$1.10B138.643,000CONConcentra Group Holdings Parent2.5486 of 5 stars$20.95+1.0%$28.50+36.0%N/A$2.69B$1.90B15.6311,250PRVAPrivia Health Group4.2389 of 5 stars$21.61-1.1%$27.77+28.5%+30.4%$2.63B$1.74B180.101,140WGSGeneDx2.2108 of 5 stars$79.71+19.0%$86.75+8.8%+227.2%$2.27B$305.45M-56.531,200Insider TradeHigh Trading VolumeVCYTVeracyte3.6016 of 5 stars$26.71+1.2%$40.90+53.1%+28.1%$2.09B$445.76M65.15790 Related Companies and Tools Related Companies Hims & Hers Health Competitors Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors GeneDx Competitors Veracyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGRY) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGRY Stock Alerts